Vaxxinity, Inc. Report issue

For profit Phase 3
Founded: Dallas TX United States (2019)

Organization Overview

First Clinical Trial
2020
NCT04545749
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Vaxxinity, Inc.